Sr. Director, Competitive Intelligence | Onsite San Diego HQ

Who We Are: Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit  neurocrine.com , and follow the company on  LinkedIn ,  X , Facebook and YouTube . ( *in collaboration with AbbVie ) About the Role: The Senior Director, Competitive Intelligence will lead Neurocrine's enterprise competitive intelligence capability across our commercial portfolio, clinical pipeline, research programs and external innovation activities. Serves as a strategic advisor to senior and executive leadership, translating complex and rapidly evolving scientific, clinical, regulatory, commercial and competitive information into clear insights that inform corporate strategy, portfolio decisions, business development, R&D strategy and commercial execution. Builds a forward-looking CI capability that goes beyond traditional monitoring and reporting. Identifies emerging competitive threats and opportunities, develops differentiated perspectives on where markets and therapeutic areas are heading, anticipates competitor actions and helps Neurocrine make better decisions earlier. Utilizes and champions modern AI tools to transform how Neurocrine collects, analyzes, synthesizes and disseminates competitive intelligence across the entire portfolio. Develops an executive-level competitive thesis and uses AI to interrogate large volumes of scientific, clinical, regulatory, financial and market information to find insights others may miss. _ Your Contributions (include, but are not limited to): Owns and leads Neurocrine's enterprise competitive intelligence strategy across marketed products, development-stage assets, research programs and emerging areas of strategic interest Develops deep competitive landscapes across Neurocrine's therapeutic areas, integrating scientific, clinical, regulatory, commercial, market access and financial perspectives Identifies emerging competitors, mechanisms, technologies and market developments before they become consensus, and assess their potential implications for Neurocrine Serves as a trusted thought partner to Corporate Strategy, Business Development, R&D, Commercial, Medical Affairs and executive leadership Translates complex competitive information into clear strategic implications and recommendations, rather than simply reporting developments Develops competitor and asset-level scenarios, including likely clinical-development strategies, regulatory paths, launch timing, positioning, commercial potential and potential competitor responses Leads competitive assessments around major catalysts, including clinical readouts, regulatory decisions, medical congresses, product launches, earnings calls and business development transactions Develops and maintains competitive landscapes, company profiles, pipeline databases, catalyst calendars and other decision-support tools across the portfolio Partners with Business Development and Corporate Strategy on external innovation, transaction evaluations, market landscapes and strategic opportunity assessments Partners with R&D teams to understand emerging biology, modalities and development strategies and identify competitive implications early in the research and development lifecycle Partners with Commercial and Medical teams to understand evolving standards of care, physician behavior, market dynamics and competitor positioning Designs and leads competitive simulations and war-gaming exercises around important clinical, regulatory and commercial events Builds an effective system for rapidly communicating material competitive developments to leadership while avoiding information overload Builds an AI-native competitive intelligence capability across Neurocrine's entire portfolio, using tools to increase the breadth, speed and depth of competitive analysis Uses large language models and other AI-enabled research and analytical tools to synthesize scientific literature, clinical-trial information, regulatory documents, patents, company disclosures, medical-congress data, market research and other structured and unstructured information Develops workflows and agents for continuous competitive monitoring, catalyst tracking, landscape development, signal detection and synthesis of large information sets Uses AI to connect information across therapeutic areas and datasets, identify weak signals and emerging patterns, generate and pressure-test hypotheses, and surface competitive developments that traditional CI approaches may miss Evaluates and implements new AI tools and data sources that materially improve Neurocrine's competitive intelligence capabilities Partners with Digital/IT, Legal, Compliance and other stakeholders to ensure appropriate and responsible use of AI and external information Builds strong relationships across functions and therapeutic areas and create an enterprise network for sharing competitive intelligence Influences decisions without direct authority and effectively challenge assumptions at senior levels of the organization